Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 14 symbols : LLY save search
Cogstate Announces Formation of Scientific Advisory Board
Published: 2022-06-14 (Crawled : 15:00) - globenewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
UCBJY | $63.31 -4.38% 9.4K
|
Manufacturing
|
| O: -0.22%
H: 0.0%
C: -1.02%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -2.24%
H: 0.0%
C: 0.0%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.4%
H: 0.33%
C: -0.91%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -0.41%
H: 0.73%
C: -0.54%
research system companies market
FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
Published: 2022-06-14 (Crawled : 03:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -2.09%
H: 0.41%
C: -1.96%
olumiant fda
Innovent Announces the NMPA Acceptance of the New Drug Application for Tafolecimab Injection (anti-PCSK-9 antibody)
Published: 2022-06-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -2.09%
H: 0.41%
C: -1.96%
drug application injection
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar) by the Indonesian Food and Drugs Authority (BPOM)
Published: 2022-06-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -2.09%
H: 0.41%
C: -1.96%
bevagen approval food drug
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.